Home » Newsletters » BioWorld Science

BioWorld Science

May 17, 2021

View Archived Issues

Osmol initiates IND-enabling studies of OSM-0205 for prevention of CIPN

Regeneron's REGN-7483F Mini-VEGF-Trap could be a next-generation VEGF inhibitor

Phase II/III XIRIUS study of cotoretigene toliparvovec in XLPR does not meet primary endpoint

SK Biopharmaceuticals divulges PRMT5 inhibitors

Gilead Sciences patents GLP-1R agonists

Kinnate Biopharma synthesizes new Raf kinase C inhibitors

ARKUDA Therapeutics identifies PGRN modulators

Shire Human Genetic Therapies describes new AAV-based gene therapy for HAE

CureVac reports promising preclinical data for its second-generation COVID-19 vaccine candidate

Combined administration of BNT-152 and BNT-153 results in synergistic antitumor effects

FDA approves Empaveli for PNH

Clinical results of an individualized multimodal immunotherapy

Phase II data on Sanofi and GSK COVID-19 vaccine candidate show favorable immune responses

Memo's MTX-COVAB shows efficacy against original SARS-CoV-2 and U.K. variant

Phase I results presented for rAAV9.U7snRNA.ACCA in DMD

Seelos reports open-label data on SLS-002 for acute suicidal ideation and behavior in MDD

New murine model of myotonic dystrophy 1 developed

Rise Biopharmaceuticals initiates phase I study of RP-72 in pancreatic cancer

Australian researchers map out first genetic profile of skeletal master regulator cells

Galera begins dosing in phase IIb study of GC-4711 in pancreatic cancer

Phase III trials of ruxolitinib in vitiligo meet endpoints